Metropolis Healthcare Ltd Share Price
(METROPOLIS)
₹1662.6
as on 04:01PM, 17 Apr 2025
Metropolis Healthcare Ltd Performance
Day's Low
Day's High
₹1,641.6Day's Price Range₹1,67052 Week's Low
52 Week's High
₹1,31552-Week Price Range₹2,318.3
| Returns % | |
| 1 Month Return | + 2.35 % |
| 3 Month Return | -12.29 % |
| 1 Year Return | -4.43 % |
| Market Stats | |
| Previous Close | ₹1,666.70 |
| Open | ₹1,665.30 |
| Volume | 1.35L |
| Upper Circuit | ₹2,000.00 |
| Lower Circuit | ₹1,333.40 |
| Market Cap | ₹8,526.00Cr |
Metropolis Healthcare Ltd Fundamentals
P/E Ratio
55.94
PEG Ratio
10.42
Market Cap
₹8,526.00 Cr
P/B Ratio
8.58
EPS
25.08
Dividend Yield
0.23
Sector
Healthcare
ROE
11.78
Mutual Fund Holdings of Metropolis Healthcare Ltd
Metropolis Healthcare Ltd Analyst Rating
based on 18 analysts
66.67%
Buy
5.56%
Hold
27.78%
Sell
Based on 18 analysts offering long term price targets for Metropolis Healthcare Ltd. An average target of ₹2063.61
Source: S&P Global Market Intelligence
Metropolis Healthcare Ltd Share analysis
Metropolis Healthcare Ltd price forecast by 18 analysts
Upside of24.12%
High
₹2740
Target
₹2063.61
Low
₹1675
Metropolis Healthcare Ltd target price ₹2063.61, a slight upside of 24.12% compared to current price of ₹1662.6. According to 18 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Metropolis Healthcare Ltd revenue growth forecast
Expected growth rate Q1, FY2027:58.29%
Forecast
Actual
Including amortisation and stock based compensations
Metropolis Healthcare Ltd EPS growth forecast
EPS estimate Q1, FY2027:114.71%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Metropolis Healthcare Ltd
Metropolis Healthcare Faces Near-Term Challenges - 10 Apr, 2025
Metropolis Healthcare's stock has declined 21% over three months due to weak performance, earnings revisions, and regulatory concerns. Anticipated disappointing Q4 results and lower revenue growth add to the pressure, although some brokerages believe the stock has fully discounted these issues.Metropolis Expands Northern Presence with Acquisition - 07 Apr, 2025
Metropolis Healthcare has acquired Dr. Ahujas Pathology and Imaging Centre for ₹35 crore, enhancing its footprint in North India. This acquisition aligns with its growth strategy and aims to boost revenue and service offerings in the region.Metropolis Healthcare Reports 10% Revenue Growth in Q4 FY25 - 05 Apr, 2025
Metropolis Healthcare achieved a 10% year-on-year revenue growth in Q4 FY25, driven by its wellness segment, despite challenges in acute testing and specialty areas. The B2C business saw a 14% revenue increase, while operational EBITDA faced constraints from higher material costs. The company remains debt-free with cash reserves of Rs 112 crore, despite acquisition-related expenses.Metropolis Healthcare Plans Strategic Acquisitions - 21 Mar, 2025
Metropolis Healthcare aims to acquire 2-3 companies annually to enhance its presence in northern and eastern India, focusing on specialty testing. The company plans to invest in high-end diagnostics and expand its network significantly, targeting revenue growth to bridge the gap with market leader Dr. Lal PathLabs.Metropolis Healthcare Grants RSUs to Employees - 17 Mar, 2025
Metropolis Healthcare Ltd. has granted 18,000 Restrictive Stock Units (RSUs) to employees under its 2020 RSU Plan, aiming to incentivize and retain talent, which may enhance operational efficiency and employee satisfaction.
Insights on Metropolis Healthcare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 24.33% to 26.37% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 191.0% return, outperforming this stock by 222.3%
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 52.4% return, outperforming this stock by 56.8%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 46.52 Cr → 31.36 Cr (in ₹), with an average decrease of 32.6% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 years, METROPOLIS stock has moved down by -31.3%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 3.99% to 3.87% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 352.92 Cr → 325.32 Cr (in ₹), with an average decrease of 7.8% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 18.56% to 16.73% in Dec 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 49.43% to 49.40% in Dec 2024 quarter
Metropolis Healthcare Ltd Financials
Metropolis Healthcare Ltd Index Inclusions
Metropolis Healthcare Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.4% | ||
| Foreign Institutions | 16.73% | ||
| Mutual Funds | 26.37% | 8.38 | |
| Retail Investors | 3.87% | ||
| Others | 3.63% |
Metropolis Healthcare Ltd Key Indicators
Metropolis Healthcare Ltd Valuation
Metropolis Healthcare Ltd in the last 5 years
Lowest (33.38x)
June 22, 2022
Today (55.94x)
April 17, 2025
Industry (101.73x)
April 17, 2025
Highest (98.05x)
September 15, 2020
Metropolis Healthcare Ltd Earnings and Dividends
Metropolis Healthcare Ltd Earnings Results
Metropolis Healthcare Ltd’s net profit jumped 15.46% since last year same period to ₹31.36Cr in the Q3 2024-2025. On a quarterly growth basis, Metropolis Healthcare Ltd has generated -32.59% fall in its net profits since last 3-months.
Read More about Earnings ResultsMetropolis Healthcare Ltd Dividends November,2023
In the quarter ending September 2023, Metropolis Healthcare Ltd has declared dividend of ₹4 - translating a dividend yield of 0.72%.
Read More about Dividends
Metropolis Healthcare Ltd Technicals Summary
Bearish
Neutral
Bullish
Metropolis Healthcare Ltd is currently in a Bullish trading position according to technical analysis indicators.
Metropolis Healthcare Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹8,526.00 Cr | 7.28% | 0.58 | ₹128 Cr | ₹1,207 Cr | |
| BUY | ₹10,681.36 Cr | 13.57% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹3,755.12 Cr | 5.78% | 0.54 | ₹69 Cr | ₹571 Cr | |
| HOLD | ₹22,687.63 Cr | 16.22% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹33,867.75 Cr | 133.8% | 0.67 | ₹168 Cr | ₹5,040 Cr |
About Metropolis Healthcare Ltd
The company offers a wide range of products and services, including clinical laboratory services, imaging services, pathology services, and wellness services. Metropolis Healthcare Ltd also provides a range of specialty services, such as genetic testing, molecular diagnostics, and bio-banking. It is one of the leading providers of healthcare services in India.
The company's top products include clinical laboratory tests, imaging services, pathology services, and wellness services. It also offers a range of popular services under the brands: Metropolis, Metropolis Health Plus, Metropolis Health Care, and Metropolis Health Care Plus.
Revenue: ₹322.77Cr as on December 2024 (Q4 24)
Net Profit: ₹31.47Cr as on December 2024 (Q4 24)
Listing date: 15 Apr, 2019
Chairperson Name: Sushil Kanubhai Shah
| Organisation | Metropolis Healthcare Ltd |
| Headquarters | |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
FAQs on Metropolis Healthcare Ltd
What is Metropolis Healthcare Ltd price today?
Metropolis Healthcare Ltd share price today stands at ₹1662.6, Open: ₹1665.3, Previous Close: ₹1666.7, High: ₹1670, Low: ₹1641.6, 52 Week High: ₹2318.3, 52 Week Low: ₹1315.
How to Buy Metropolis Healthcare Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Metropolis Healthcare Ltd shares
What are today's traded volumes of Metropolis Healthcare Ltd?
Today's traded volume of Metropolis Healthcare Ltd(METROPOLIS) is 1.35L.
What is today's market capitalisation of Metropolis Healthcare Ltd?
Today's market capitalisation of Metropolis Healthcare Ltd(METROPOLIS) is ₹8526Cr.
What is the 52 Week High and Low Range of Metropolis Healthcare Ltd?
How much percentage Metropolis Healthcare Ltd is down from its 52 Week High?
Metropolis Healthcare Ltd (METROPOLIS) share price is ₹1662.6. It is down -28.28% from its 52 Week High price of ₹2318.3
How much percentage Metropolis Healthcare Ltd is up from its 52 Week low?
Metropolis Healthcare Ltd (METROPOLIS) share price is ₹1662.6. It is up 26.43% from its 52 Week Low price of ₹1315